Arkolith/Insider Trading/VBHI/Form 4

Cox Scott

Chief Executive Officer, DirectorVERDE BIO HOLDINGS, INC. (VBHI) · full profile →Form 4 · filed Feb 17, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
24
24 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 17, 2023Buy(P)10K—$08.7M
Feb 17, 2023Buy(P)56K—$08.7M
Feb 17, 2023Buy(P)77—$08.7M
Feb 17, 2023Buy(P)101K—$08.7M
Feb 17, 2023Buy(P)278K—$08.7M
Feb 17, 2023Buy(P)50K—$08.7M
Feb 17, 2023Buy(P)50K—$08.7M
Feb 17, 2023Buy(P)25K—$08.7M
Feb 17, 2023Buy(P)10K—$08.7M
Feb 17, 2023Buy(P)5K—$08.7M
Feb 17, 2023Buy(P)50K—$08.7M
Feb 17, 2023Buy(P)50K—$08.7M
Feb 16, 2023Buy(P)3K—$08.7M
Feb 16, 2023Buy(P)250K—$08.7M
Feb 16, 2023Buy(P)50K—$08.7M
Feb 16, 2023Buy(P)250K—$08.7M
Feb 16, 2023Buy(P)100K—$08.7M
Feb 16, 2023Buy(P)50K—$08.7M
Feb 16, 2023Buy(P)197K—$08.7M
Feb 14, 2023Buy(P)6K—$08.7M
Feb 14, 2023Buy(P)3K—$08.7M
Feb 14, 2023Buy(P)11K—$08.7M
Feb 2, 2023Buy(P)8K—$08.7M
Jan 31, 2023Buy(P)7K—$08.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001949210-23-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML